3 'targeted' cancer drugs raise risk of fatal side effects

Treatment with three "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. The risk for the fatal side effects remains low, but they should be factored in when developing patients' treatment plans. Read more